Amphastar Pharma (AMPH) Tops Q2 EPS by 28c
Tweet
Share
E-mail
Get Alerts AMPH Hot Sheet
Join SI Premium – FREE
Amphastar Pharma (NASDAQ: AMPH) reported Q2 EPS of $0.91, $0.28 better than the analyst estimate of $0.63. Revenue for the quarter came in at $183.9 million versus the consensus estimate of $179.71 million.
For earnings history and earnings-related data on Amphastar Pharma (AMPH) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Interface (TILE) Tops Q2 EPS by 24c ; Offers Guidance
- Once Upon a Farm (OFRM) Reports Q2 Loss of $0.12
- Barclays: 'we see PENN's positive earnings revision cycle intact'
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
